| 3312 |
1392: Increase, Oxidative Stress |
352: N/A, Neurodegeneration |
Jul 23, 2024 |
Jul 23, 2024 |
2 AOPs
|
| 3314 |
1392: Increase, Oxidative Stress |
386: Neuronal network function, Decreased |
Jul 23, 2024 |
Jul 23, 2024 |
1 AOP
|
| 3316 |
1392: Increase, Oxidative Stress |
2244: Altered Stress Response Signaling |
Jul 24, 2024 |
Aug 26, 2024 |
2 AOPs
|
| 3319 |
1392: Increase, Oxidative Stress |
2245: Altered cell differentiation signaling |
Jul 24, 2024 |
Aug 23, 2024 |
1 AOP
|
| 3322 |
1392: Increase, Oxidative Stress |
618: Decreased, Neuronal network function in adult brain |
Jul 24, 2024 |
Jul 24, 2024 |
1 AOP
|
| 3324 |
1392: Increase, Oxidative Stress |
131: Down Regulation, Gulcose-6-phosphate dehydrogenase |
Jul 24, 2024 |
Jul 24, 2024 |
1 AOP
|
| 3325 |
1392: Increase, Oxidative Stress |
250: Damaging, Red blood cells; hemolysis |
Jul 24, 2024 |
Jul 24, 2024 |
1 AOP
|
| 3382 |
1392: Increase, Oxidative Stress |
1553: Increase mutations |
Nov 6, 2024 |
Nov 6, 2024 |
1 AOP
|
| 3442 |
1392: Increase, Oxidative Stress |
467: Increased, LDL uptake |
Nov 25, 2024 |
Nov 25, 2024 |
1 AOP
|
| 3602 |
1392: Increase, Oxidative Stress |
1446: Decrease, Coupling of OXPHOS |
Aug 21, 2025 |
Aug 21, 2025 |
3 AOPs
|
| 3616 |
1392: Increase, Oxidative Stress |
495: Repressed expression of steroidogenic enzymes |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3632 |
1392: Increase, Oxidative Stress |
1767: Increase, Protein oxidation |
Sep 8, 2025 |
Sep 8, 2025 |
5 AOPs
|
| 3690 |
1392: Increase, Oxidative Stress |
2363: Mito ROS dysfunction |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 1362 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1281: Increased, DNA Damage-Repair |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1364 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1280: Activation, HIF-1 |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 3166 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
177: Increase, Mitochondrial dysfunction |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 3512 |
1279: Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK |
1115: Increase, ROS |
Apr 3, 2025 |
Apr 3, 2025 |
1 AOP
|
| 2340 |
1865: Increase, OEC damage |
1862: Decrease, Photosystem II efficiency |
Apr 11, 2021 |
Apr 11, 2021 |
1 AOP
|
| 3552 |
2337: Increase, PLIN2 |
2333: Increase, Fat mass |
Jul 25, 2025 |
Jul 25, 2025 |
1 AOP
|
| 1241 |
1173: Increase, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1230 |
1170: Increase, Phenotypic enzyme activity |
716: Increase, cell proliferation (hepatocytes) |
Nov 29, 2016 |
Dec 31, 2020 |
1 AOP
|
| 1231 |
1170: Increase, Phenotypic enzyme activity |
1171: Increase, Clonal Expansion of Altered Hepatic Foci |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2409 |
1892: increase, placental insufficiency |
1893: increase, Preeclampsia |
May 31, 2021 |
May 31, 2021 |
1 AOP
|
| 254 |
220: Increase, Plasma vitellogenin concentrations |
252: Increase, Renal pathology due to VTG deposition |
Nov 29, 2016 |
Jun 24, 2024 |
2 AOPs
|
| 3259 |
220: Increase, Plasma vitellogenin concentrations |
364: Impaired development of, Reproductive organs |
Jul 3, 2024 |
Jul 3, 2024 |
1 AOP
|